Difficult to Diagnose Mesothelioma Cancer Has Testing through Immunohistochemistry
Wednesday, May 13th, 2009Mesothelioma is a uncommon and aggressive tumor for which no successful therapy is around despite the finding of several probable molecular targets. The final stages of MPM diagnosis and the long time that connects contacts and diagnosis have made it difficult to fully study the role of risk factors and the resulting molecular effects.
Quite a [...]